Publicacions
-
Salas S, Agut-Quijano T, Rovira-Zurriaga C, Canizo D, Lavarino C and García-Alix A.
Infratentorial congenital glioblastoma multiforme. A rare tumour with a still unknown biology
REVISTA DE NEUROLOGIA . 63(9): 411-414. Nº de cites: 2
-
Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
CANCER LETTERS . 380(1): 10-19. Nº de cites: 26
-
Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein
Oncotarget . 7(29): 46283-46300. Nº de cites: 12
-
Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.
Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens
Oncotarget . 7(13): 16112-16129. Nº de cites: 17
-
Gomez-Gonzalez S, Castellano G, Mayol G, Queiros A, Martín-Subero JI and Lavarino C.
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
Genomics data . 5: 360-363. Nº de cites: 5
-
Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.
Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts
PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Nº de cites: 10
-
Mora J, Cruz-Martínez O, Lavarino C, Rios J, Vancells M, Parareda A, Salvador-Hernandez H, Suñol M, Carrasco-Torrents R, Guillen-Quesada A, Mañé S and de Torres C.
Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7)
CLINICAL & TRANSLATIONAL ONCOLOGY . 17(7): 521-529. Nº de cites: 12
-
Gomez-Gonzalez S, Castellano G, Mayol G, Suñol M, Queiros A, Bibikova M, Nazor KL, Loring JF, Lemos I, Rodríguez E, de Torres C, Mora J, Martín-Subero JI and Lavarino C.
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
EPIGENOMICS . 7(7): 1137-1153. Nº de cites: 36
-
Ottenhoff MJ, Mous SE, Castricum J, Rietman AB, Oostenbrink R, van der Vaart T, Tulen JHM, Parra-Checa A, Ramos F, Legius E, Moll HA, Elgersma Y and de Wit MY.
Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trial.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY . : . Nº de cites: 1
-
Zhang D, Sánchez-Espino LF, Ivars M, Pope E, Nopper AJ, Arkin LM, Tollefson MM, Lavarino C, Muldowney M, Gene-Olaciregui N, Paco-Mercader S, Drolet BA and Baselga E.
Phenotypic Spectrum of GNA11 R183C Mosaicism.
PEDIATRIC DERMATOLOGY . : .